Search results for "Sistema nerviós"

showing 10 items of 32 documents

Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.

2013

Paraneoplastic myelitis is a rare inflammatory disorder most frequently associated with solid tumors or lymphoproliferative disorders. Patients often harbor onconeuronal antibodies and their prognosis is usually poor. Here we report a 42-year old woman with longitudinally extensive transverse myelitis and aquaporin-4 (AQP4) antibodies that led to the diagnosis of ovarian teratoma. After tumor removal and immune therapy (including corticosteroids, plasma exchange, intravenous immunoglobulins and rituximab) the patient progressively improved achieving complete recovery. Histological study of the teratoma demonstrated neural tissue containing AQP4 expressing cells and intense inflammatory infi…

AdultPathologymedicine.medical_specialtyImmunologyLymphoproliferative disordersMyelitis TransverseAutoimmune diseases Paraneoplastic syndrome Transverse myelitisTransverse myelitisDiagnosis DifferentialmedicineImmunology and AllergyHumansNeurociènciesOvarian TeratomaAutoantibodiesAquaporin 4Ovarian Neoplasmsbiologybusiness.industryParaneoplastic MyelitisTeratomamedicine.diseaseNeurologybiology.proteinRituximabFemaleSistema nerviós MalaltiesNeurology (clinical)TeratomaAntibodybusinessBiomarkersmedicine.drugInflammatory disorder
researchProduct

Effect of Foot Orthoses and Shoes in Parkinson's Disease Patients : A PRISMA Systematic Review

2021

[Abstract] Reduced plantar foot sensation, postural instability, and gait difficulties are characteristic of Parkinson´s disease patients. A systematic review was carried out to determine the effect of the different types of insoles and shoes in these patients. Several databases were used to search for relevant articles reporting Parkinson´s disease patients undergoing treatment with any type of insole and footwear. All titles and abstracts were reviewed independently by two reviewers and the available data were extracted. The study eligibility criteria were any type of experimental study that included Parkinson’s disease patients treated with any type of insole or footwear. Eight studies w…

Balancemedicine.medical_specialtyPasoParkinson's diseasePostural instabilityMedicine (miscellaneous)EquilibrioReviewControlled studiesinsolegaitFootwearInsolePhysical medicine and rehabilitationSensationmedicineFoot OrthosesGaitBalance (ability)PlantillaImportant conclusionbusiness.industryRbalancemedicine.diseaseGaitParkinson diseaseExtremitatsPodologíaCalzadoEnfermedad de ParkinsonfootwearParkinson’s diseaseMedicineSistema nerviós Malaltiesbusiness
researchProduct

Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture

2022

Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels and however, no effects of Rn on cellular sensitivity to insulin (Ins) have been demonstrated yet. The present study aimed to investigate the permissive effects of Rn on the actions of Ins in astrocytes in primary culture. Ins at 10-8 M, Rn (10-6 M) and Ins+Rn (10-8 M and 10−6 M respectively) were added to astrocytes during 24 h. In comparison to control cells, Rn and/or Ins caused modifications in cell viability and proliferation. p-AKT, p-ERK, p-eNOS, Mn-SOD, COX-2, and t…

Blood Glucoseranolazine; insulin; astrocytes; inflammation; antioxidantsSuperoxide DismutaseSistema nerviós central MalaltiesOrganic ChemistryAnti-Inflammatory AgentsNF-kappa Bendocrinology_metabolomicsGeneral MedicineCatalysisAntioxidantsComputer Science ApplicationsPPAR gammaInorganic ChemistryCyclooxygenase 2RanolazineAstrocytesInsulin Regular HumanInsulinPhysical and Theoretical ChemistryProto-Oncogene Proteins c-aktMolecular BiologySpectroscopy
researchProduct

WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture

2015

Alzheimer's disease (AD), a neurodegenerative illness involving synaptic dysfunction with extracellular accumulation of Aβ1-42 toxic peptide, glial activation, inflammatory response and oxidative stress, can lead to neuronal death. Endogenous cannabinoid system is implicated in physiological and physiopathological events in central nervous system (CNS), and changes in this system are related to many human diseases, including AD. However, studies on the effects of cannabinoids on astrocytes functions are scarce. In primary cultured astrocytes we studied cellular viability using MTT assay. Inflammatory and oxidative stress mediators were determined by ELISA and Western-blot techniques both in…

Cannabinoid receptormedicine.medical_treatmentInterleukin-1betaNitric Oxide Synthase Type IIlcsh:Medicinemedicine.disease_causeReceptors CannabinoidWIN 55212-2Receptorlcsh:ScienceCerebral CortexMultidisciplinaryCalcium Channel BlockersSistema nerviós Malaltiesmedicine.symptomSignal transductionResearch ArticleSignal Transductionmedicine.drugmedicine.medical_specialtyCell SurvivalMorpholinesPrimary Cell CultureInflammationNaphthalenesBiologyNeurologiaFetusInternal medicinemedicineAnimalsViability assayCannabinoid Receptor AgonistsAmyloid beta-PeptidesSuperoxide DismutaseTumor Necrosis Factor-alphalcsh:RTranscription Factor RelAPeptide FragmentsBenzoxazinesRatsPPAR gammaOxidative StressEndocrinologyGene Expression RegulationCyclooxygenase 2Astrocyteslcsh:QFisiologia humanaCannabinoidOxidative stress
researchProduct

Risk factors for central nervous system tumors in children: New findings from a case-control study

2017

BACKGROUND: Central nervous system tumors (CNS) are the most frequent solid tumor in children. Causes of CNS tumors are mainly unknown and only 5% of the cases can be explained by genetic predisposition. We studied the effects of environmental exposure on the incidence of CNS tumors in children by subtype, according to exposure to industrial and/or urban environment, exposure to crops and according to socio-economic status of the child. METHODS: We carried out a population-based case-control study of CNS tumors in Spain, covering 714 incident cases collected from the Spanish Registry of Childhood Tumors (period 1996-2011) and 4284 controls, individually matched by year of birth, sex, and au…

Central Nervous SystemMaleUrban PopulationSocial Scienceslcsh:MedicineNervous SystemUrban EnvironmentsCentral Nervous System NeoplasmsFamilies0302 clinical medicineSociologyRisk FactorsEpidemiology of cancerMedicine and Health SciencesMedicine030212 general & internal medicinelcsh:ScienceChildNeurological TumorsChildrenGeographic AreasAir PollutantsMultidisciplinaryGeographyAgricultureGliomaPlantsTerrestrial EnvironmentsOncologyNeurology030220 oncology & carcinogenesisChild PreschoolFemaleAnatomyInfantsResearch ArticleUrban Areasmedicine.medical_specialtyAdolescentCropsAstrocytomaFruits03 medical and health sciencesHumansSocial StratificationPesticidesSistema nerviós centralbusiness.industryEcology and Environmental Scienceslcsh:ROrganismsCase-control studyInfant NewbornBiology and Life SciencesCancers and NeoplasmsCancerInfantEnvironmental Exposuremedicine.diseaseSocial ClassAge GroupsCentral nervous systemFamily medicineCase-Control StudiesPeople and PlacesEarth SciencesPopulation Groupingslcsh:QbusinessCrop Science
researchProduct

Ultrasound-Guided Percutaneous Neuromodulation in Patients with Chronic Lateral Epicondylalgia: A Pilot Randomized Clinical Trial

2021

Objective: The aim was to analyze effects of a percutaneous neuromodulation (PNM) treatment on the radial nerve, regarding pain, functionality, electrophysiologic excitability, and morphology, in patients with chronic lateral epicondylalgia (LE). Methods: Twenty-four patients with chronic unilateral elbow pain were recruited for this preliminary study and were divided into two groups: control (n = 12) and PNM group (n = 12). The subjects in the PNM group received percutaneous peripheral neurostimulation with an acupuncture needle that was located next to the nerve with ultrasound guidance. Pain using a numerical rating scale (NRS), functional ability using patient-rated tennis elbow evaluat…

ChronaxieHealth Toxicology and Mutagenesismedicine.medical_treatmentPilot ProjectsChronic painlaw.invention0302 clinical medicineRandomized controlled triallawlateral epicondylalgiaFunctional abilityFisioterapiapercutaneous nerve stimulationPain MeasurementUltrasonography030222 orthopedicseducation.field_of_studyultrasoundNeuromodulationPercutaneous nerve stimulationRehabilitationRLateral epicondylalgiaChronic painAnesthesianeuromodulationMedicineEnfermeríaSistema nerviós Malaltieschronic painPopulationEnfermería Fisioterapia y PodologíaArticlerehabilitation03 medical and health sciencesUltrasoundmedicineTennis elbowHumansSistema musculoesqueléticoRadial nerveeducationNeurostimulationUltrasonography InterventionalRadial nervebusiness.industryPublic Health Environmental and Occupational HealthTennis Elbowmedicine.diseaseradial nerveRehabilitacióbusiness030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation

2021

Parkinson’s disease is a common neurodegenerative disease and it is known to cause motor disturbances associated with musculoskeletal problems of the locomotor apparatus, and non-motor symptoms, that are believed to have a harmful effect on health, social functioning and mobility. The aim of this study was to evaluate depression in patients with Parkinson’s Disease (PD) compared to subjects who do not have it. The sample consisted of 124 participants (mean age 69.18 ± 9.12). Patients with PD were recruited from a center of excellence for Parkinson’s disease (cases n = 62) and healthy subjects without PD from their relatives and caregivers (control n = 62). The Spanish version of Beck’s Depr…

Inventario de Depresión de Beckmedicine.medical_specialtyParkinson's diseaseHealth Toxicology and MutagenesisBeck Depression InventoryNeurocienciaslcsh:MedicineDiseasebehavioral disciplines and activitiesArticle03 medical and health sciences0302 clinical medicineInternal medicineDepresiónmedicineHumansIn patient030212 general & internal medicineDepression (differential diagnoses)Social functioningAgedbusiness.industryDepressionSignificant differencelcsh:RPublic Health Environmental and Occupational HealthHealthy subjectsBeck Depression InventoryNeurodegenerative DiseasesParkinson DiseaseMiddle Agedmedicine.diseasehumanitiesPsicologíaParkinson diseaseCaregiversbeck depression inventoryEnfermedad de ParkinsonCase-Control StudiesdepressionSistema nerviós Malaltiesbusiness030217 neurology & neurosurgery
researchProduct

Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration

2021

(1) Background: A non-progressive congenital ataxia (NPCA) phenotype caused by b-III spectrin (SPTBN2) mutations has emerged, mimicking spinocerebellar ataxia, autosomal recessive type 14 (SCAR14). The pattern of inheritance, however, resembles that of autosomal dominant classical spinocerebellar ataxia type 5 (SCA5). (2) Methods: In-depth phenotyping of two boys studied by a customized gene panel. Candidate variants were sought by structural modeling and protein expression. An extensive review of the literature was conducted in order to better characterize the SPTBN2-associated NPCA. (3) Results: Patients exhibited an NPCA with hypotonia, developmental delay, cerebellar syndrome, and cogni…

Male0301 basic medicineProbandPathologyProtein ConformationSequence Homology<i>SPTBN2 </i>geneb-III spectrin030105 genetics & heredityFluid-attenuated inversion recoveryCohort Studieslcsh:ChemistryNon-progressive congenital ataxia0302 clinical medicineβ-III spectrinSpectrin:enfermedades del sistema nervioso::enfermedades neurodegenerativas [ENFERMEDADES]Age of OnsetChildlcsh:QH301-705.5Spectroscopy:Otros calificadores::Otros calificadores::/genética [Otros calificadores]NeurodegenerationneurodegenerationNeurodegenerative Diseasesnon-progressive congenital ataxiaSyndromeGeneral MedicinePhenotypeHypotoniaComputer Science ApplicationsPhenotype:Nervous System Diseases::Neurodegenerative Diseases [DISEASES]Spinocerebellar ataxiamedicine.symptomSPTBN2 genemedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesCerebellar AtaxiaNeuroimagingBiologyCatalysisArticleInorganic Chemistry03 medical and health sciences:Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebellar Diseases::Cerebellar Ataxia [DISEASES]:Other subheadings::Other subheadings::/genetics [Other subheadings]medicineHumansAmino Acid SequencePhysical and Theoretical ChemistryNeurodegenerationMolecular BiologyGenetic Association StudiesOrganic ChemistrySpectrinmedicine.diseaseHyperintensitySistema nerviós - Degeneració - Aspectes genèticslcsh:Biology (General)lcsh:QD1-999:enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::enfermedades cerebelosas::ataxia cerebelosa [ENFERMEDADES]Mutation030217 neurology & neurosurgeryInternational Journal of Molecular Sciences
researchProduct

FOXP2 expression and gray matter density in the male brains of patients with schizophrenia

2021

Common genetic variants ofFOXP2may contribute to schizophrenia vulnerability, but controversial results have been reported for this proposal. Here we evaluated the potential impact of the commonFOXP2rs2396753 polymorphism in schizophrenia. It was previously reported to be part of a risk haplotype for this disease and to have significant effects on gray matter concentration in the patients. We undertook the first examination into whether rs2396753 affects the brain expression ofFOXP2and a replication study of earlier neuroimaging findings of the influence of this genetic variant on brain structure.FOXP2expression levels were measured in postmortem prefrontal cortex samples of 84 male subject…

MaleCandidate geneSistema nerviós central MalaltiesFOXP2Cognitive NeurosciencePhysiologyBiology03 medical and health sciencesBehavioral NeuroscienceCellular and Molecular NeuroscienceMagnetic resonance imaging0302 clinical medicinemaleNeuroimagingexpressionGenetic variationmedicinemagnetic resonance imagingHumansRadiology Nuclear Medicine and imagingGray MatterPrefrontal cortexOriginal ResearchCerebral Cortexmedicine.diagnostic_testlanguage lateralizationsevere speechBrain morphometrysyndrome scale panssassociationNeuropsychologyBrainForkhead Transcription FactorsMagnetic resonance imagingFOXP2gray matterdisorder030227 psychiatryschizophreniaPsychiatry and Mental healthNeurologySchizophreniaEsquizofrèniagenetic-variationNeurology (clinical)polymorphisms030217 neurology & neurosurgeryBrain Imaging and Behavior
researchProduct

Kinesiophobia Levels in Patients with Parkinson’s Disease: A Case-Control Investigation

2021

Background: Kinesiophobia can be an obstacle to physical and motor activity in patients with Parkinson’s disease (PD). PD affects patients’ independence in carrying out daily activities. It also impacts a patient’s biopsychosocial well-being. The objective of this study was to analyze the levels and scores of kinesiophobia in PD patients and compare them with healthy volunteers. Methods: We deployed a case-control study and recruited 124 subjects (mean age 69.18 ± 9.12). PD patients were recruited from a center of excellence for Parkinson’s disease (cases n = 62). Control subjects were recruited from the same hospital (control n = 62). Kinesiophobia total scores and categories were self-rep…

Moderate to severemedicine.medical_specialtyMovement disordersActivities of daily livingParkinson's diseaseKinesiophobiaHealth Toxicology and MutagenesisNeurocienciasFisiologiaMedicina Física y RehabilitaciónArticle03 medical and health sciencesMusculoskeletal and neural physiological phenomena0302 clinical medicineSurveys and QuestionnairesmedicineHumansIn patientMotor activityMovement disordersFisioterapiaAgedbusiness.industryPublic Health Environmental and Occupational HealthRParkinson Disease030229 sport sciencesmusculoskeletal and neural physiological phenomenaFearMiddle Agedmedicine.diseaseCase-Control StudiesMann–Whitney U testPhysical therapyParkinson’s diseasemovement disordersMedicineSistema nerviós Malaltiesmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct